US20170361046A1 - Patient interface and non-invasive positive pressure ventilating method - Google Patents
Patient interface and non-invasive positive pressure ventilating method Download PDFInfo
- Publication number
- US20170361046A1 US20170361046A1 US15/692,479 US201715692479A US2017361046A1 US 20170361046 A1 US20170361046 A1 US 20170361046A1 US 201715692479 A US201715692479 A US 201715692479A US 2017361046 A1 US2017361046 A1 US 2017361046A1
- Authority
- US
- United States
- Prior art keywords
- seal
- patient
- patient interface
- space
- face
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
- A61M16/0605—Means for improving the adaptation of the mask to the patient
- A61M16/0616—Means for improving the adaptation of the mask to the patient with face sealing means comprising a flap or membrane projecting inwards, such that sealing increases with increasing inhalation gas pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/42—Reducing noise
Definitions
- Sample embodiments of the present invention relate to a patient interface for use in delivering a flow of breathable gas to an airway of a patient. Sample embodiments of the present invention also relate to a non-invasive positive pressure ventilating method.
- Non-invasive positive pressure ventilation (NIPPV) techniques such as, for example, the application of continuous positive airway pressure (CPAP) have been used to treat sleep disorder breathing (SDB) such as obstructive sleep apnea (OSA) and other disorders such as chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF).
- SDB sleep disorder breathing
- COPD chronic obstructive pulmonary disease
- CHF congestive heart failure
- Apparatuses for applying NIPPV techniques typically include a flow generator, including a blower, and a patient interface.
- a delivery conduit or hose is connected between the flow generator and the patient interface to deliver breathable gas at a positive pressure to the patient.
- a number of different patient interfaces are known and include, for example, nasal masks, nose and mouth masks, full-face masks, and nasal prongs and pillows.
- a headgear is typically utilized to position the patient interface on the patient's face and counterbalance the force of gravity and the force
- NIPPV therapies are typically administered at night while the patient sleeps.
- the patient interface In order for the therapy to be effective, the patient interface must be comfortable enough for the patient to remain sleeping, while maintaining a seal that is sufficient to deliver the breathable air at the required pressure.
- Air leakage from between the patient's skin and the patient interface reduces the effectiveness of the therapy. Even very small leaks can be perceived by the patient and/or bed partner.
- the air leakage may cause the patient to increase the pressure of the mask against the patient's face.
- the air leakage may also cause the flow generator to increase the pressure of the delivered air, thus increasing the speed and noise of the flow generator.
- Increasing the pressure of the delivered air results in an increase in the flow of air, including the vent flow and leak flow.
- a humidifier is used, the increase in the leak flow results in a waste of water from the humidifier.
- supplemental oxygen is being provided to the flow of air, the increase in the leak flow causes a waste of some of the supplemental oxygen.
- the air leakage may act as an irritant to the patient's eyes and disturb the patient's sleep.
- One aspect of the invention relates to a patient interface that improves therapy to a patient by reducing, or eliminating, problems caused by leakage from the patient interface.
- Another aspect of the invention relates to a patient interface that improves therapy to a patient by reducing, or eliminating, patient discomfort caused by leakage from the patient interface.
- Yet another aspect of the invention relates to a patient interface that reduces, or eliminates, the occurrence of explosive, or bursting, leakage.
- Still another aspect of the invention relates to a patient interface that can catch or collect leakage from a first seal with a second seal to prevent leakage from the patient interface.
- An even further aspect of the invention relates to a patient interface that increases the resistance to leakage.
- a still further aspect of the invention relates to a patient interface that diffuses leakage to reduce irritation to the patient.
- Another aspect of the invention relates to a patient interface that vents or deflects leakage to reduce or prevent disturbance to the patient.
- a patient interface for use in delivering a flow of breathable gas to an airway of a patient.
- the patient interface comprises a first seal adapted to contact the patient's face and seal a first space between the patient interface and the patient's face at a first positive pressure; and a second seal adapted to contact the patient's face and seal a second space between the patient interface and the patient's face at a second positive pressure.
- the first seal is configured to seal the first space from the second space.
- a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a seal adapted to contact the patient's face and seal a space between the patient interface and the patient's face at a positive pressure; and a leak reducing means provided on the seal for reducing leakage of gas from the space.
- a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a first seal adapted to contact the patient's face and seal a first space between the patient interface and the patient's face at a first positive pressure; and a second seal adapted to contact the patient's face and seal a second space between the patient interface and the patient's face.
- a vacuum line is configured to create a negative pressure in the second space and remove any gas leaking from the first space to the second space. The negative pressure is sufficient to deform the first and second seals and a portion of the patient's face covered by the second space.
- a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a frame; and a conduit for delivering the flow of breathable gas.
- the conduit is incorporated with the frame.
- a seal is connected to the conduit.
- the seal is inflatable by the flow of breathable gas to pressurize the seal against the patient's face and includes a vent to direct the flow of breathable gas to a space between the patient interface and the patient's face.
- a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a seal adapted to contact the patient's face and seal a space between the patient interface and the patient's face.
- the sealed space includes a nasal bridge region of the patient's face.
- a cuff is provided over the seal in the nasal bridge region to direct any leakage of the gas flow from the seal in the nasal bridge region in a direction away from the patient's eyes.
- a non-invasive positive pressure ventilating method comprises delivering a flow of breathable gas to a patient interface; sealing a first space between the patient interface and the patient's face at a first positive pressure; and sealing a second space between the patient interface and the patient's face at a second positive pressure. The first space is sealed from the second space.
- a non-invasive positive pressure ventilating method comprises delivering a flow of breathable gas to a patient interface; sealing a first space between the patient interface and the patient's face at a first positive pressure; and diffusing any leakage from the sealed first space.
- a non-invasive positive pressure ventilating method comprises delivering a flow of breathable gas to a patient interface; sealing a first space between the patient interface and the patient's face at a first positive pressure; and deflecting any leakage of air from the first space in a nasal bridge region away from the patient's eyes.
- FIG. 1 is a model according to an example of the present invention that illustrates leakage from a patient interface having two seals in series;
- FIG. 2 is a model according to an example of the present invention that illustrates different possible conditions and resulting statuses that may evolve for a patient interface having two seals provided in series;
- FIG. 3 a illustrates a patient interface
- FIGS. 3 b , 3 c , 3 d , and 3 e illustrate different foam shapes that may be used with the patient interface of FIG. 3 a;
- FIG. 4 illustrates a patient interface according to another embodiment of the present invention
- FIG. 5 illustrates a patient interface according to another embodiment of the invention
- FIG. 6 illustrates a patient interface according to another embodiment of the invention.
- FIGS. 7 a and 7 b illustrate a patient interface according to another embodiment of the invention.
- FIG. 8 illustrates a patient interface according to another embodiment of the invention.
- FIG. 9 illustrates a sectioned patient interface according to another embodiment of the invention.
- FIG. 10 is a diagram illustrating the operation of a patient interface having a primary seal and a secondary seal in accordance with another embodiment of the invention.
- FIG. 11 illustrates a patient interface and an air delivery hose in accordance with another embodiment of the invention.
- air will be taken to include breathable gases, for example air with supplemental oxygen. It is also acknowledged that the blowers described herein may be designed to pump fluids and/or gases other than air.
- a patient interface may include two seals S 1 , S 2 that are provided in series. Each seal S 1 , S 2 has a resistance R 1 , R 2 , respectively, to leakage.
- a pressure P 1 is delivered at the patient interface by a flow generator.
- a pressure P 2 exists between the two seals S 1 , S 2 .
- Ambient pressure P amb is provided outside the patient interface.
- a leak flow Q 1 flows across the first seal S 1 .
- a pressure P 2 develops as a result of the leak flow Q 1 .
- the pressure P 2 is a positive pressure, i.e., greater than ambient pressure P amb . If the pressure P 2 is greater than the maximum pressure P 2max that the seal S 2 can withstand, a second leak flow Q 2 flows across the second seal S 2 and out of the patient interface into the ambient air.
- the space between the first and second seals S 1 , S 2 has a volume V 2 that contains a volumetric mass ⁇ 2 of breathable gas (e.g. air).
- breathable gas e.g. air
- a seal arrangement for a patient interface may be designed to collect and/or control any possible leakage, including any leakage between the first and second seals, and/or any leakage from the second seal, i.e., leakage out of the patient interface.
- seal arrangement may be designed to avoid leakage by sealing properly under any condition. The seal arrangement should thus be designed to avoid leakage that causes annoyance and/or discomfort to the patient, and to improve the quality of the therapy by reducing, or eliminating, problems associated with leakage, e.g., disruption of bi-level algorithms for control of the flow generator.
- a seal arrangement for a patient interface according to the invention may be designed to prevent explosive leak from the patient interface.
- the seal arrangement according to examples of the invention may also be designed to reduce or eliminate noise disturbance to the patient, and to reduce or eliminate eye irritation by reducing or eliminating leakage.
- Other design objectives than those specifically discussed herein may also be considered.
- condition C 1 is changed by another condition C 2 that increases the pressure P 1 delivered at the patient interface by the flow generator so that the pressure P 1 exceeds the maximum sealing pressure P 1max of the first seal P 1
- another set of conditions C 3 occurs at the patient interface.
- the pressure P 1 delivered by the flow generator exceeds the maximum sealing pressure P 1max of the first seal S 1 , and also exceeds the pressure P 2 between the first and second seals S 1 , S 2 and the ambient pressure P amb .
- a leak flow Q 1 occurs across the first seal S 1 .
- Q 2 0. Accordingly, there is no leakage from the patient interface to the ambient.
- the leak flow Q 1 across the first seal S 1 may cause the pressure P 2 between the first seal S 1 and the second seal S 2 to increase (condition C 4 ).
- additional design conditions C 5 , C 9 may effect the performance of the patient interface.
- the maximum sealing pressure P 1max of the first seal S 1 is less than the maximum sealing pressure P 2max of the second seal S 2 .
- the patient interface assumes a first status S 1 .
- the second seal S 2 is in sealing engagement with the patient's face to prevent leakage.
- the first seal S 1 does not seal against the patient's face, but may return to a sealing engagement upon a change of condition(s).
- the second seal S 2 may open and allow an explosive leak of air from the patient interface. If the first seal S 1 is not in sealing condition, a short circuit may occur when the cushion moves so that a leak flow occurs across both the first and second seals S 1 and S 2 .
- condition C 8 if the pressure P 1 at the patient interface delivered by the flow generator exceeds the maximum sealing pressure P 2max of the second seal (condition C 8 ), another condition C 10 develops. It is also possible for the condition C 10 to develop when the pressure P 2 between the first and second seals is increasing (condition C 4 ) and the maximum sealing pressure P 1max of the first seal S 1 is greater than the maximum sealing pressure P 2max of the second seal S 2 (condition C 9 ).
- a leak flow Q includes a leak flow Q 1 across the first seal S 1 and a leak flow Q 2 across the second seal S 2 .
- condition C 13 If the leak flow Q 1 across the first seal S 1 is greater than the leak flow Q 2 across the second seal S 2 (condition C 13 ) and the pressure P 2 between the first and second seals is increasing such that the pressure P 2 is greater than the maximum sealing pressure P 2max of the second seal S 2 (condition C 14 ), the leak flows Q 1 , Q 2 across the first and second seals S 1 , S 2 will equalize to a value greater than 0 (condition C 15 ) This condition C 15 may also result directly from condition C 10 if the leak flows Q 1 , Q 2 across the first and second seals S 1 , S 2 are both greater than zero and equal to each other.
- condition C 15 the pressure P 1 at the patient interface delivered by the flow generator is greater than the pressure P 2 between the first and second seals, which is greater than ambient pressure. If this condition C 15 is present, the patient interface is in a second status S 2 in which there is a continuous leak, or short circuit, through both the first and second seals. As discussed below, various seal arrangements may be designed to reduce or eliminate the problems associated with a continuous leak as occurs in the second status S 2 .
- the model discussed above with respect to FIG. 2 may rely on certain assumptions. For example, it may be assumed that there are no relative movements between the patient's face and the patient interface. It may also be assumed that a leak flow occurs when the pressure across the seal exceeds the maximum sealing pressure of the seal, i.e., when P>P max . Another assumption that may be made is that the pressure P 1 that is supplied by the flow generator is constant. Furthermore, it may be assumed that the volume V 2 between the first and second seals is constant.
- the model may also take into account variations to those assumptions. For example, relative movements between the frame of the patient interface and the patient's face may be interpreted as variations of the maximum sealing pressure P 1max , P 2max of the first and second seals S 1 , S 2 .
- a patient interface 10 includes a cushion 12 having a filler layer 14 provided on the cushion 12 .
- the filler layer 14 is adapted to be in contact with the patient's skin.
- the cushion 12 may be formed of, for example, silicone and the filler layer 14 may be formed of, for example, foam.
- the filler layer 14 may be, for example, adhesively attached to the cushion 12 , for example by glue.
- the filler layer 14 may also be mechanically connected to the frame of the mask as a skin that envelops the cushion. In that case, the filler layer 14 may be replaced, for example in a manner similar to replacing the foam over earphones.
- the filler layer 14 may be connected at the same location as the cushion, on the cushion itself, or at another point on the frame.
- the filler layer 14 may also be silicone foam injected over the silicone cushion 12 so that the cushion and the filler layer are a single object.
- the filler layer 14 serves to fill gaps between the cushion 12 and the patient's skin.
- the filler layer 14 also reduces, or eliminates, vibrations of the cushion 12 and reduces any leak flow by increasing the resistance of the seal formed by the cushion 12 .
- the filler layer 14 also diffuses any leak flow that may occur. Moreover, any leak flow passing through the filler layer 14 may inflate the filler layer 14 and permit the patient's skin to breathe.
- the filler layer 14 may be uniform in cross sectional shape and material, or the filler layer 14 may be made of differing materials in different areas 14 a - 14 d and also differing shapes (as shown in FIG. 3 b ).
- the filler layer may be a closed loop or selected areas may be left empty.
- an interface 22 may include a seal 24 in contact with the patient's skin 20 .
- a diffuser 26 e.g., of foam material
- the diffuser 26 may be connected to the seal 24 in a manner similar to the connection of the filler layer 14 to the cushion 12 of the first embodiment.
- the seal 24 of the interface 22 and the diffuser 26 are provided in series and both contact the patient's face.
- the “sealing” provided by the seal 24 and diffuser 26 is broader than the “sealing” provided by the first embodiment as the seal 24 and the diffuser increase the resistance to leak flow.
- the diffuser 26 may be a porous material, for example a porous material that provides a high resistance to leak flow while providing compliance with the patient's face.
- the diffuser 26 may be mechanically connected to the interface 22 in a manner similar to the mechanical connection of the filler layer 14 to the cushion 12 discussed above with respect to the first embodiment.
- the diffuser 26 may also be silicone foam injected on the interface so that they are a single object.
- the diffuser 26 may also be attached to the interface 22 adhesively. Although the diffuser 26 is shown in FIG. 4 as being provided on the exterior of the interface 22 , it should be appreciated that the diffuser may be provided in the interior of the interface 22 and diffuse any leak flow before it passes the seal 24 . Such a configuration may also prevent explosive leakage from the interface 22 .
- an interface 22 includes a primary seal 24 adapted to contact the patient's skin 20 .
- the primary seal 24 may be, for example, silicone.
- a secondary seal 32 is placed inside the interface 22 and may also be in contact with the patient's face.
- the secondary seal 32 may be, for example, foam.
- the space between the primary seal 24 and a secondary seal 32 includes secondary vents 30 which are provided in addition to primary vents 28 .
- a vent flow VF is vented through the primary vents 28 .
- the volume between the primary seal 24 and the secondary seal 32 is vented through secondary vents 30 to create a local low-pressure area near the primary seal 24 , i.e. P 2 ⁇ P 1 . Any leak flow across the secondary seal 32 will be vented through the secondary vents 30 .
- the secondary vents 30 may be placed in an area of the patient interface where the vented leak flow Q will not disturb the patient.
- an air delivery hose or conduit 34 may be incorporated into a frame of the patient interface.
- the conduit 34 is connected to an inflatable cushion 36 .
- the inflatable cushion 36 may comprise a hollow gel seal.
- the inflatable cushion 36 is pressurized against the patient's skin 20 by pressure force and the force caused by the deflection of the air flow through vents 38 formed in the inflatable cushion 36 that deliver the breathable gas to the patient.
- the flow generator of the breathing apparatus supplies breathable gas via the hose or conduit 34 to the patient interface.
- the hose or conduit 34 may be connected to the patient interface by an elbow, for example a swivel elbow. The flow generator delivers the flow to the elbow at a pressure P 1 .
- the pressure P 1 drops to a pressure P 2 which inflates the inflatable cushion 36 .
- the pressure of the flow of breathable gas is further reduced by the resistance of the vents 38 , and the pressure drops to the therapy pressure P T .
- FIGS. 7 a and 7 b A patient interface according to another embodiment of the invention is shown in FIGS. 7 a and 7 b .
- the patient interface 22 includes first and second seals 40 , 42 which form a seal against the patient's skin 20 .
- a vacuum line 44 sucks any leak flow that may occur between the first and second seals 40 and 42 and deforms the seals 40 and 42 , and the skin between them, into the position shown in FIG. 7 b .
- the seals 40 and 42 may be formed, for example, as gel cushions.
- the vacuum may only be switched on, for example, when the second space is at a pressure higher than ambient.
- a leak cuff 46 may be provided over a seal 44 of a patient interface in the nasal bridge area of the patient's face. Any leak flow passing the seal 44 is directed by the leak cuff 46 around the nose bridge 45 of the patient and away from the patient's eyes 47 as shown by the arrows in FIG. 8 , effectively redirecting the leak flow. It should be appreciated that the leak cuff 46 may be provided around the perimeter of the entire patient interface, or may be provided only in the nasal bridge region. It should also be appreciated that the leak cuff 46 may be configured to seal against the patient' face. It should further be appreciated that the leak cuff 46 may be provided to a dual wall cushion, in which case the leak cuff 46 may take the form of a third wall.
- a patient interface 10 a according to another embodiment of the invention shown in FIG. 9 includes a first seal 50 and a second seal 52 .
- the patient interface 10 a also includes a convergent-divergent nozzle 54 in an elbow 64 attached to the patient interface 10 a creating a Bernoulli effect. Any leak flow 58 that occurs between the first seal 50 and the second seal 52 is effectively re-circulated by the nozzle 54 .
- the re-circulated leak flow 60 is added to the flow 62 delivered by the flow generator to provide a supply 66 of breathable gas to the patient.
- the pressure between the first seal 50 and the second seal 52 should be lower than the pressure in the patient interface 10 a, but slightly higher than the ambient pressure in order to avoid loss of the leak flow 58 to the ambient.
- a patient interface may include a primary seal and secondary seal.
- the primary seal has a higher maximum sealing pressure P max at a lower displacement of the patient interface with respect to the patient's face than the secondary seal.
- P max maximum sealing pressure
- Such an arrangement may include a deformable patient interface frame, such as a mask frame, that automatically adjusts according to the load condition placed on the frame.
- the secondary seal After a certain amount of displacement, the secondary seal has a maximum sealing pressure P max that is higher than the maximum sealing pressure P max of the primary seal.
- the maximum overall sealing pressure P max of the combination of the primary seal and the secondary seal is higher than either the maximum sealing pressure of the primary seal or the secondary seal alone.
- the patient interface 10 b is connected to an air delivery conduit or hose 70 .
- the conduit 70 includes a localized area 72 having a high axial deformability that can compensate for the pull of the conduit 70 on the patient interface 10 b (i.e. tube drag).
- the conduit 70 may also be a retractable tube, for example as disclosed in U.S. Applications 60/973,902, filed Sep. 20, 2007, 60/987,825, filed Nov. 14, 2007, and 61/031,407, filed Feb. 26, 2008, the entire contents of all three being incorporated herein by reference.
- NIPPV Continuous Positive Airway Pressure
- VPAP Variable Positive Airway Pressure
- BiPAP Bi-level Positive Airway Pressure
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 12/134,801, filed Jun. 6, 2008, now allowed, which claims priority to U.S.
Provisional Application 60/949,692, filed Jul. 13, 2007, each of which is incorporated herein by reference in their entirety. - Sample embodiments of the present invention relate to a patient interface for use in delivering a flow of breathable gas to an airway of a patient. Sample embodiments of the present invention also relate to a non-invasive positive pressure ventilating method.
- Non-invasive positive pressure ventilation (NIPPV) techniques, such as, for example, the application of continuous positive airway pressure (CPAP) have been used to treat sleep disorder breathing (SDB) such as obstructive sleep apnea (OSA) and other disorders such as chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF). Apparatuses for applying NIPPV techniques typically include a flow generator, including a blower, and a patient interface. A delivery conduit or hose is connected between the flow generator and the patient interface to deliver breathable gas at a positive pressure to the patient. A number of different patient interfaces are known and include, for example, nasal masks, nose and mouth masks, full-face masks, and nasal prongs and pillows. A headgear is typically utilized to position the patient interface on the patient's face and counterbalance the force of gravity and the force which results from the application of pressurized air which seeks to push the mask off the face.
- NIPPV therapies are typically administered at night while the patient sleeps. In order for the therapy to be effective, the patient interface must be comfortable enough for the patient to remain sleeping, while maintaining a seal that is sufficient to deliver the breathable air at the required pressure.
- Air leakage from between the patient's skin and the patient interface reduces the effectiveness of the therapy. Even very small leaks can be perceived by the patient and/or bed partner. The air leakage may cause the patient to increase the pressure of the mask against the patient's face. The air leakage may also cause the flow generator to increase the pressure of the delivered air, thus increasing the speed and noise of the flow generator. Increasing the pressure of the delivered air results in an increase in the flow of air, including the vent flow and leak flow. If a humidifier is used, the increase in the leak flow results in a waste of water from the humidifier. If supplemental oxygen is being provided to the flow of air, the increase in the leak flow causes a waste of some of the supplemental oxygen. Moreover, the air leakage may act as an irritant to the patient's eyes and disturb the patient's sleep.
- Various masks have been proposed for minimizing leakage between the mask cushion and the face of the patient. Examples of these respiratory masks are disclosed in U.S. Patent Application Publication 2003/0029455, U.S. Pat. No. 6,418,928 and WO Patent Application Publication 2006/113321. Other approaches to minimizing leakage include attempting to provide a perfect seal between the patient's face and the patient interface. U.S. Pat. No. 6,834,650 is an example of such an attempt. WO Patent Application Publication 2006/102707 discloses a patient interface having a vacuum line as a return path from the patient interface. Leakage is prevented, but requires the use of non-vented patient interfaces.
- There still exists a need for a patient interface that controls leakage and improves therapy for the patient by reducing, or eliminating, the main discomfiture associated with leakage.
- One aspect of the invention relates to a patient interface that improves therapy to a patient by reducing, or eliminating, problems caused by leakage from the patient interface.
- Another aspect of the invention relates to a patient interface that improves therapy to a patient by reducing, or eliminating, patient discomfort caused by leakage from the patient interface.
- Yet another aspect of the invention relates to a patient interface that reduces, or eliminates, the occurrence of explosive, or bursting, leakage.
- Still another aspect of the invention relates to a patient interface that can catch or collect leakage from a first seal with a second seal to prevent leakage from the patient interface.
- An even further aspect of the invention relates to a patient interface that increases the resistance to leakage.
- A still further aspect of the invention relates to a patient interface that diffuses leakage to reduce irritation to the patient.
- Another aspect of the invention relates to a patient interface that vents or deflects leakage to reduce or prevent disturbance to the patient.
- According to one embodiment of the invention a patient interface for use in delivering a flow of breathable gas to an airway of a patient is provided. The patient interface comprises a first seal adapted to contact the patient's face and seal a first space between the patient interface and the patient's face at a first positive pressure; and a second seal adapted to contact the patient's face and seal a second space between the patient interface and the patient's face at a second positive pressure. The first seal is configured to seal the first space from the second space.
- According to another embodiment of the invention, a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a seal adapted to contact the patient's face and seal a space between the patient interface and the patient's face at a positive pressure; and a leak reducing means provided on the seal for reducing leakage of gas from the space.
- According to a further embodiment of the invention, a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a first seal adapted to contact the patient's face and seal a first space between the patient interface and the patient's face at a first positive pressure; and a second seal adapted to contact the patient's face and seal a second space between the patient interface and the patient's face. A vacuum line is configured to create a negative pressure in the second space and remove any gas leaking from the first space to the second space. The negative pressure is sufficient to deform the first and second seals and a portion of the patient's face covered by the second space.
- According to yet another embodiment of the invention, a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a frame; and a conduit for delivering the flow of breathable gas. The conduit is incorporated with the frame. A seal is connected to the conduit. The seal is inflatable by the flow of breathable gas to pressurize the seal against the patient's face and includes a vent to direct the flow of breathable gas to a space between the patient interface and the patient's face.
- According to still another embodiment of the invention, a patient interface for use in delivering a flow of breathable gas to an airway of a patient comprises a seal adapted to contact the patient's face and seal a space between the patient interface and the patient's face. The sealed space includes a nasal bridge region of the patient's face. A cuff is provided over the seal in the nasal bridge region to direct any leakage of the gas flow from the seal in the nasal bridge region in a direction away from the patient's eyes.
- According to another embodiment of the invention, a non-invasive positive pressure ventilating method comprises delivering a flow of breathable gas to a patient interface; sealing a first space between the patient interface and the patient's face at a first positive pressure; and sealing a second space between the patient interface and the patient's face at a second positive pressure. The first space is sealed from the second space.
- According to still another embodiment of the invention, a non-invasive positive pressure ventilating method comprises delivering a flow of breathable gas to a patient interface; sealing a first space between the patient interface and the patient's face at a first positive pressure; and diffusing any leakage from the sealed first space.
- According to a further embodiment, a non-invasive positive pressure ventilating method comprises delivering a flow of breathable gas to a patient interface; sealing a first space between the patient interface and the patient's face at a first positive pressure; and deflecting any leakage of air from the first space in a nasal bridge region away from the patient's eyes.
- Other aspects, features, and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.
- The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:
-
FIG. 1 is a model according to an example of the present invention that illustrates leakage from a patient interface having two seals in series; -
FIG. 2 is a model according to an example of the present invention that illustrates different possible conditions and resulting statuses that may evolve for a patient interface having two seals provided in series; -
FIG. 3a illustrates a patient interface; -
FIGS. 3b, 3c, 3d, and 3e illustrate different foam shapes that may be used with the patient interface ofFIG. 3 a; -
FIG. 4 illustrates a patient interface according to another embodiment of the present invention; -
FIG. 5 illustrates a patient interface according to another embodiment of the invention; -
FIG. 6 illustrates a patient interface according to another embodiment of the invention; -
FIGS. 7a and 7b illustrate a patient interface according to another embodiment of the invention; -
FIG. 8 illustrates a patient interface according to another embodiment of the invention; -
FIG. 9 illustrates a sectioned patient interface according to another embodiment of the invention; -
FIG. 10 is a diagram illustrating the operation of a patient interface having a primary seal and a secondary seal in accordance with another embodiment of the invention; and -
FIG. 11 illustrates a patient interface and an air delivery hose in accordance with another embodiment of the invention. - The following description is provided in relation to several embodiments which may share common characteristics and features. It is to be understood that one or more features of any one embodiment may be combinable with one or more features of the other embodiments. In addition, any single feature or combination of features in any of the embodiments may constitute additional embodiments.
- In this specification, the word “comprising” is to be understood in its “open” sense, that is, in the sense of “including”, and thus not limited to its “closed” sense, that is the sense of “consisting only of”. A corresponding meaning is to be attributed to the corresponding words “comprise”, “comprised” and “comprises” where they appear.
- The term “air” will be taken to include breathable gases, for example air with supplemental oxygen. It is also acknowledged that the blowers described herein may be designed to pump fluids and/or gases other than air.
- Patient Interface Models
- Referring to
FIG. 1 , a patient interface may include two seals S1, S2 that are provided in series. Each seal S1, S2 has a resistance R1, R2, respectively, to leakage. A pressure P1 is delivered at the patient interface by a flow generator. A pressure P2 exists between the two seals S1, S2. Ambient pressure Pamb is provided outside the patient interface. - When the pressure P1 delivered at the patient interface by the flow generator is greater than the maximum pressure P1max that the first seal can withstand, then the seal S1 breaks and a leak flow Q occurs against the resistance R1. Initially, a leak flow Q1 flows across the first seal S1. In the space between the first seal S1 and the second seal S2, a pressure P2 develops as a result of the leak flow Q1. The pressure P2 is a positive pressure, i.e., greater than ambient pressure Pamb. If the pressure P2 is greater than the maximum pressure P2max that the seal S2 can withstand, a second leak flow Q2 flows across the second seal S2 and out of the patient interface into the ambient air.
- The space between the first and second seals S1, S2 has a volume V2 that contains a volumetric mass ρ2 of breathable gas (e.g. air).
- Various conditions may be present at the patient interface. In designing a seal arrangement for a patient interface, the various conditions may be considered in addition to the desired status of the patient interface. For example, the seal arrangement of the patient interface may be designed to collect and/or control any possible leakage, including any leakage between the first and second seals, and/or any leakage from the second seal, i.e., leakage out of the patient interface. As another example, seal arrangement may be designed to avoid leakage by sealing properly under any condition. The seal arrangement should thus be designed to avoid leakage that causes annoyance and/or discomfort to the patient, and to improve the quality of the therapy by reducing, or eliminating, problems associated with leakage, e.g., disruption of bi-level algorithms for control of the flow generator.
- Although a seal arrangement that prevents all leakage, i.e., a perfect seal, would be the most desired arrangement, such an arrangement is very difficult to achieve. Such a seal arrangement may have a desired effect in a relatively small number of cases, for example in high pressure bi-level devices. A more practical seal arrangement may be provided to control leakage when it occurs. Such an arrangement would have a desired effect in a larger number of cases. Controlling leakage allows the flow generator to react properly to leakage, and thus improves the delivery of the therapy. Controlling leakage may also prevent the leakage from causing patient discomfort. Preventing disturbance of the patient's sleep is one way to ensure proper treatment.
- A seal arrangement for a patient interface according to the invention may be designed to prevent explosive leak from the patient interface. The seal arrangement according to examples of the invention may also be designed to reduce or eliminate noise disturbance to the patient, and to reduce or eliminate eye irritation by reducing or eliminating leakage. Other design objectives than those specifically discussed herein may also be considered.
- Referring to
FIG. 2 , a model which may be used in designing patient interfaces according to examples of the invention is illustrated. As shown in condition C1, when the maximum sealing pressure P1max of the first seal S1 is larger than the pressure P1 delivered at the mask by the flow generator, and greater than the pressure P2 between the first and second seals S1, S2, there is no leak flow across the first and second seals S1, S2, i.e., Q=Q1=Q2=0. - If the condition C1 is changed by another condition C2 that increases the pressure P1 delivered at the patient interface by the flow generator so that the pressure P1 exceeds the maximum sealing pressure P1max of the first seal P1, another set of conditions C3 occurs at the patient interface. Under the conditions C3, the pressure P1 delivered by the flow generator exceeds the maximum sealing pressure P1max of the first seal S1, and also exceeds the pressure P2 between the first and second seals S1, S2 and the ambient pressure Pamb. Under these conditions C3, a leak flow Q1 occurs across the first seal S1. However, there is no leak flow across the second seal S2, i.e., Q2=0. Accordingly, there is no leakage from the patient interface to the ambient.
- The leak flow Q1 across the first seal S1 may cause the pressure P2 between the first seal S1 and the second seal S2 to increase (condition C4). As the pressure P2 between the first and second seals S1, S2 increases, additional design conditions C5, C9 may effect the performance of the patient interface. Under a first design condition C5, the maximum sealing pressure P1max of the first seal S1 is less than the maximum sealing pressure P2max of the second seal S2. Under this design condition C5, if the pressure P1 delivered by the flow generator at the patient interface is less than or equal to the maximum sealing pressure P2max of the second seal S2 (condition C6), then the pressure P2 between the first and second seals S1, S2 equals the pressure P1 delivered by the flow generator (condition C7) As delivered pressure P1 is less than the maximum sealing pressure P2max of the second seal S2, the leak flow Q, including the leak flow Q1 across the first seal and the leak flow Q2 across the second seal S2=0.
- When the conditions C1-C7 discussed above are satisfied, the patient interface assumes a first status S1. In this status S1, the second seal S2 is in sealing engagement with the patient's face to prevent leakage. The first seal S1 does not seal against the patient's face, but may return to a sealing engagement upon a change of condition(s). When the patient interface is in the first status S1, and the cushion is moved, such as during the patient's sleep session, the second seal S2 may open and allow an explosive leak of air from the patient interface. If the first seal S1 is not in sealing condition, a short circuit may occur when the cushion moves so that a leak flow occurs across both the first and second seals S1 and S2.
- Referring back to the condition C5 (P1max<P2max), if the pressure P1 at the patient interface delivered by the flow generator exceeds the maximum sealing pressure P2max of the second seal (condition C8), another condition C10 develops. It is also possible for the condition C10 to develop when the pressure P2 between the first and second seals is increasing (condition C4) and the maximum sealing pressure P1max of the first seal S1 is greater than the maximum sealing pressure P2max of the second seal S2 (condition C9).
- In condition C10, the pressure P2 between the first and second seals exceeds the maximum sealing pressure P2max of the second seal S2. The pressure P1 delivered by the flow generator also is greater than the pressure P2 between the seals, which is greater than the ambient pressure Pamb. Under this condition C10, a leak flow Q includes a leak flow Q1 across the first seal S1 and a leak flow Q2 across the second seal S2.
- If the flow Q1 across the first seal S1 is less than the flow Q2 across the second seal S2 (C11) and the pressure P2 between the first and second seals is decreasing such that the pressure P2 is less than or equal to the maximum sealing pressure P2max of the second seal S2 (C12), the patient interface returns to condition C3. In condition C3, there is a flow Q1 across the first seal S1, but no flow across the second seal S2 (i.e. Q2=0). This can cause cyclic explosive leaks.
- If the leak flow Q1 across the first seal S1 is greater than the leak flow Q2 across the second seal S2 (condition C13) and the pressure P2 between the first and second seals is increasing such that the pressure P2 is greater than the maximum sealing pressure P2max of the second seal S2 (condition C14), the leak flows Q1, Q2 across the first and second seals S1, S2 will equalize to a value greater than 0 (condition C15) This condition C15 may also result directly from condition C10 if the leak flows Q1, Q2 across the first and second seals S1, S2 are both greater than zero and equal to each other.
- In condition C15, the pressure P1 at the patient interface delivered by the flow generator is greater than the pressure P2 between the first and second seals, which is greater than ambient pressure. If this condition C15 is present, the patient interface is in a second status S2 in which there is a continuous leak, or short circuit, through both the first and second seals. As discussed below, various seal arrangements may be designed to reduce or eliminate the problems associated with a continuous leak as occurs in the second status S2.
- The model discussed above with respect to
FIG. 2 may rely on certain assumptions. For example, it may be assumed that there are no relative movements between the patient's face and the patient interface. It may also be assumed that a leak flow occurs when the pressure across the seal exceeds the maximum sealing pressure of the seal, i.e., when P>Pmax. Another assumption that may be made is that the pressure P1 that is supplied by the flow generator is constant. Furthermore, it may be assumed that the volume V2 between the first and second seals is constant. - Although certain assumptions, such as those discussed above, may be relied upon in modeling the behavior of the patient interface, the model may also take into account variations to those assumptions. For example, relative movements between the frame of the patient interface and the patient's face may be interpreted as variations of the maximum sealing pressure P1max, P2max of the first and second seals S1, S2.
- Referring to
FIGS. 3a and 3b , apatient interface 10 according to one embodiment of the invention includes acushion 12 having afiller layer 14 provided on thecushion 12. Thefiller layer 14 is adapted to be in contact with the patient's skin. Thecushion 12 may be formed of, for example, silicone and thefiller layer 14 may be formed of, for example, foam. Thefiller layer 14 may be, for example, adhesively attached to thecushion 12, for example by glue. Thefiller layer 14 may also be mechanically connected to the frame of the mask as a skin that envelops the cushion. In that case, thefiller layer 14 may be replaced, for example in a manner similar to replacing the foam over earphones. Thefiller layer 14 may be connected at the same location as the cushion, on the cushion itself, or at another point on the frame. Thefiller layer 14 may also be silicone foam injected over thesilicone cushion 12 so that the cushion and the filler layer are a single object. Thefiller layer 14 serves to fill gaps between thecushion 12 and the patient's skin. Thefiller layer 14 also reduces, or eliminates, vibrations of thecushion 12 and reduces any leak flow by increasing the resistance of the seal formed by thecushion 12. Thefiller layer 14 also diffuses any leak flow that may occur. Moreover, any leak flow passing through thefiller layer 14 may inflate thefiller layer 14 and permit the patient's skin to breathe. Thefiller layer 14 may be uniform in cross sectional shape and material, or thefiller layer 14 may be made of differing materials indifferent areas 14 a-14 d and also differing shapes (as shown inFIG. 3b ). The filler layer may be a closed loop or selected areas may be left empty. - As shown in
FIG. 4 , aninterface 22 may include aseal 24 in contact with the patient'sskin 20. A diffuser 26 (e.g., of foam material) is provided outside theseal 24 of theinterface 22 to increase the resistance to leak flow Q and diffuse any leak flow that may actually occur. Thediffuser 26 may be connected to theseal 24 in a manner similar to the connection of thefiller layer 14 to thecushion 12 of the first embodiment. However, unlike the first embodiment, in which only thefiller layer 14 contact the patient's face, according to the second embodiment theseal 24 of theinterface 22 and thediffuser 26 are provided in series and both contact the patient's face. Accordingly, in the second embodiment the “sealing” provided by theseal 24 anddiffuser 26 is broader than the “sealing” provided by the first embodiment as theseal 24 and the diffuser increase the resistance to leak flow. It should be appreciated that the seal may provide very little, or no resistance, to leak flow while thediffuser 26 may be configured to limit the leak flow to small values. Thediffuser 26 may be a porous material, for example a porous material that provides a high resistance to leak flow while providing compliance with the patient's face. Thediffuser 26 may be mechanically connected to theinterface 22 in a manner similar to the mechanical connection of thefiller layer 14 to thecushion 12 discussed above with respect to the first embodiment. Thediffuser 26 may also be silicone foam injected on the interface so that they are a single object. Thediffuser 26 may also be attached to theinterface 22 adhesively. Although thediffuser 26 is shown inFIG. 4 as being provided on the exterior of theinterface 22, it should be appreciated that the diffuser may be provided in the interior of theinterface 22 and diffuse any leak flow before it passes theseal 24. Such a configuration may also prevent explosive leakage from theinterface 22. - Referring to
FIG. 5 , aninterface 22 includes aprimary seal 24 adapted to contact the patient'sskin 20. Theprimary seal 24 may be, for example, silicone. Asecondary seal 32 is placed inside theinterface 22 and may also be in contact with the patient's face. Thesecondary seal 32 may be, for example, foam. The space between theprimary seal 24 and asecondary seal 32 includessecondary vents 30 which are provided in addition toprimary vents 28. A vent flow VF is vented through the primary vents 28. The volume between theprimary seal 24 and thesecondary seal 32 is vented throughsecondary vents 30 to create a local low-pressure area near theprimary seal 24, i.e. P2<P1. Any leak flow across thesecondary seal 32 will be vented through the secondary vents 30. Thesecondary vents 30 may be placed in an area of the patient interface where the vented leak flow Q will not disturb the patient. - Referring to
FIG. 6 , an air delivery hose orconduit 34 may be incorporated into a frame of the patient interface. Theconduit 34 is connected to aninflatable cushion 36. Theinflatable cushion 36 may comprise a hollow gel seal. Theinflatable cushion 36 is pressurized against the patient'sskin 20 by pressure force and the force caused by the deflection of the air flow throughvents 38 formed in theinflatable cushion 36 that deliver the breathable gas to the patient. The flow generator of the breathing apparatus supplies breathable gas via the hose orconduit 34 to the patient interface. The hose orconduit 34 may be connected to the patient interface by an elbow, for example a swivel elbow. The flow generator delivers the flow to the elbow at a pressure P1. Due to the resistance of the hose or conduit, and the elbow if provided, the pressure P1 drops to a pressure P2 which inflates theinflatable cushion 36. The drop in pressure is in the hose or conduit, and optional elbow, is ΔP1=P1−P2. The pressure of the flow of breathable gas is further reduced by the resistance of thevents 38, and the pressure drops to the therapy pressure PT. The pressure drop from the vents is ΔP2=P2−PT. Therefore, in order for the correct therapy pressure PT to be delivered to the patient, the pressure P1 supplied by the flow generator is P1=PT+ΔP2+ΔP1. - A patient interface according to another embodiment of the invention is shown in
FIGS. 7a and 7b . Thepatient interface 22 includes first andsecond seals skin 20. Avacuum line 44 sucks any leak flow that may occur between the first andsecond seals seals FIG. 7b . Theseals - According to another embodiment of the invention shown in
FIG. 8 , aleak cuff 46 may be provided over aseal 44 of a patient interface in the nasal bridge area of the patient's face. Any leak flow passing theseal 44 is directed by theleak cuff 46 around the nose bridge 45 of the patient and away from the patient's eyes 47 as shown by the arrows inFIG. 8 , effectively redirecting the leak flow. It should be appreciated that theleak cuff 46 may be provided around the perimeter of the entire patient interface, or may be provided only in the nasal bridge region. It should also be appreciated that theleak cuff 46 may be configured to seal against the patient' face. It should further be appreciated that theleak cuff 46 may be provided to a dual wall cushion, in which case theleak cuff 46 may take the form of a third wall. - A
patient interface 10 a according to another embodiment of the invention shown inFIG. 9 includes afirst seal 50 and asecond seal 52. Thepatient interface 10 a also includes a convergent-divergent nozzle 54 in anelbow 64 attached to thepatient interface 10 a creating a Bernoulli effect. Any leak flow 58 that occurs between thefirst seal 50 and thesecond seal 52 is effectively re-circulated by thenozzle 54. There-circulated leak flow 60 is added to theflow 62 delivered by the flow generator to provide asupply 66 of breathable gas to the patient. - The pressure between the
first seal 50 and thesecond seal 52 should be lower than the pressure in thepatient interface 10 a, but slightly higher than the ambient pressure in order to avoid loss of theleak flow 58 to the ambient. - Referring to
FIG. 10 , a patient interface may include a primary seal and secondary seal. The primary seal has a higher maximum sealing pressure Pmax at a lower displacement of the patient interface with respect to the patient's face than the secondary seal. When the patient interface is displaced, the maximum sealing pressure of Pmax of the primary seal decreases while the maximum sealing pressure Pmax of the secondary seal increases. Such an arrangement may include a deformable patient interface frame, such as a mask frame, that automatically adjusts according to the load condition placed on the frame. After a certain amount of displacement, the secondary seal has a maximum sealing pressure Pmax that is higher than the maximum sealing pressure Pmax of the primary seal. As shown inFIG. 10 , the maximum overall sealing pressure Pmax of the combination of the primary seal and the secondary seal is higher than either the maximum sealing pressure of the primary seal or the secondary seal alone. - It is also possible to reduce the leak flow from the patient interface by considering other components of the breathing apparatus. As shown in
FIG. 11 , thepatient interface 10 b is connected to an air delivery conduit orhose 70. Theconduit 70 includes a localizedarea 72 having a high axial deformability that can compensate for the pull of theconduit 70 on thepatient interface 10 b (i.e. tube drag). Theconduit 70 may also be a retractable tube, for example as disclosed inU.S. Applications 60/973,902, filed Sep. 20, 2007, 60/987,825, filed Nov. 14, 2007, and 61/031,407, filed Feb. 26, 2008, the entire contents of all three being incorporated herein by reference. - It should be appreciated that the sample embodiments disclosed herein may be used in various NIPPV therapies, including Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP), and Bi-level Positive Airway Pressure (BiPAP). In these therapies, a pressurized flow of breathable gas, e.g. air, may be supplied to a patient's airways at a pressure of, for example, between 4
cm H 20 to 20cm H 20. - While the invention has been described in connection with what are presently considered to be the most practical embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. Furthermore, each individual component of any given assembly, one or more portions of an individual component of any given assembly, and various combinations of components from one or more embodiments may include one or more ornamental design features. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, barriatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/692,479 US20170361046A1 (en) | 2007-07-13 | 2017-08-31 | Patient interface and non-invasive positive pressure ventilating method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94969207P | 2007-07-13 | 2007-07-13 | |
US12/134,801 US9782553B2 (en) | 2007-07-13 | 2008-06-06 | Patient interface and non-invasive positive pressure ventilating method |
US15/692,479 US20170361046A1 (en) | 2007-07-13 | 2017-08-31 | Patient interface and non-invasive positive pressure ventilating method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/134,801 Continuation US9782553B2 (en) | 2007-07-13 | 2008-06-06 | Patient interface and non-invasive positive pressure ventilating method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20170361046A1 true US20170361046A1 (en) | 2017-12-21 |
Family
ID=40252089
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/134,801 Active 2034-11-20 US9782553B2 (en) | 2007-07-13 | 2008-06-06 | Patient interface and non-invasive positive pressure ventilating method |
US15/692,479 Abandoned US20170361046A1 (en) | 2007-07-13 | 2017-08-31 | Patient interface and non-invasive positive pressure ventilating method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/134,801 Active 2034-11-20 US9782553B2 (en) | 2007-07-13 | 2008-06-06 | Patient interface and non-invasive positive pressure ventilating method |
Country Status (1)
Country | Link |
---|---|
US (2) | US9782553B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021245668A1 (en) * | 2020-06-03 | 2021-12-09 | Inspir Labs Ltd. | Medical ventilation mask |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005079726A1 (en) | 2004-02-23 | 2005-09-01 | Fisher & Paykel Healthcare Limited | Breathing assistance apparatus |
AU2005228827C1 (en) | 2004-04-02 | 2022-02-03 | Fisher & Paykel Healthcare Limited | Breathing assistance apparatus |
EP4252811A3 (en) | 2006-07-14 | 2023-11-29 | Fisher & Paykel Healthcare Limited | Breathing assistance apparatus |
EP2051760B1 (en) | 2006-07-28 | 2014-03-12 | ResMed Limited | Patient interface |
JP2009544371A (en) | 2006-07-28 | 2009-12-17 | レスメド・リミテッド | Providing respiratory therapy |
WO2008070929A1 (en) | 2006-12-15 | 2008-06-19 | Resmed Ltd | Delivery of respiratory therapy |
US9387301B2 (en) * | 2006-12-19 | 2016-07-12 | Koninklijke Philips N.V. | Pad assembly having outer casing and support element |
CN107137810B (en) | 2008-03-04 | 2021-07-23 | 瑞思迈私人有限公司 | Interface comprising a foam cushion element |
US8746248B2 (en) * | 2008-03-31 | 2014-06-10 | Covidien Lp | Determination of patient circuit disconnect in leak-compensated ventilatory support |
US8267085B2 (en) | 2009-03-20 | 2012-09-18 | Nellcor Puritan Bennett Llc | Leak-compensated proportional assist ventilation |
US10207069B2 (en) | 2008-03-31 | 2019-02-19 | Covidien Lp | System and method for determining ventilator leakage during stable periods within a breath |
US8272379B2 (en) | 2008-03-31 | 2012-09-25 | Nellcor Puritan Bennett, Llc | Leak-compensated flow triggering and cycling in medical ventilators |
US10792451B2 (en) | 2008-05-12 | 2020-10-06 | Fisher & Paykel Healthcare Limited | Patient interface and aspects thereof |
US10258757B2 (en) | 2008-05-12 | 2019-04-16 | Fisher & Paykel Healthcare Limited | Patient interface and aspects thereof |
US11660413B2 (en) | 2008-07-18 | 2023-05-30 | Fisher & Paykel Healthcare Limited | Breathing assistance apparatus |
EP3266483B1 (en) * | 2008-08-04 | 2023-09-27 | Fisher & Paykel Healthcare Limited | Respiratory mask sealing interface |
NZ615630A (en) | 2008-09-12 | 2015-05-29 | Resmed Ltd | A foam-based interfacing structure method and apparatus |
US20100071696A1 (en) * | 2008-09-25 | 2010-03-25 | Nellcor Puritan Bennett Llc | Model-predictive online identification of patient respiratory effort dynamics in medical ventilators |
ES2904590T3 (en) | 2008-10-10 | 2022-04-05 | Fisher & Paykel Healthcare Ltd | Nasal pillows for a patient interface |
EP2213324B1 (en) | 2009-01-30 | 2016-07-27 | ResMed R&D Germany GmbH | Patient interface structure and method/tool for manufacturing same |
US8424521B2 (en) * | 2009-02-27 | 2013-04-23 | Covidien Lp | Leak-compensated respiratory mechanics estimation in medical ventilators |
US8418691B2 (en) * | 2009-03-20 | 2013-04-16 | Covidien Lp | Leak-compensated pressure regulated volume control ventilation |
WO2010148453A1 (en) * | 2009-06-24 | 2010-12-29 | Resmed Ltd | Adjustable mask system and related methods |
WO2011062510A1 (en) | 2009-11-18 | 2011-05-26 | Fisher & Paykel Healthcare Limited | Nasal interface |
JP5863049B2 (en) | 2009-11-20 | 2016-02-16 | レスメド・リミテッドResMedLimited | Mask system |
CN105854138B (en) | 2009-12-23 | 2022-09-16 | 费雪派克医疗保健有限公司 | Patient interface and mask |
ES2546868T3 (en) | 2010-01-25 | 2015-09-29 | Vosschemie Gmbh | Apparatus for the production of a putty ready for use by mixing a binder component and a hardener |
US20110209701A1 (en) * | 2010-03-01 | 2011-09-01 | Laura Derringer | Nose pad cushion and applicator for respiratory mask |
US9339626B2 (en) | 2010-03-16 | 2016-05-17 | Carefusion 207, Inc. | Seal for variable compression interfaces |
WO2011121463A1 (en) * | 2010-03-31 | 2011-10-06 | Koninklijke Philips Electronics N.V. | Respiratory mask with ribbed contacting surface |
EP2624903B1 (en) | 2010-10-08 | 2018-05-16 | Fisher & Paykel Healthcare Limited | Breathing assistance apparatus |
US20140202469A1 (en) * | 2011-01-03 | 2014-07-24 | Balboa Manufacturing Company, Llc | Adjustable facial conforming face mask |
US10137269B2 (en) | 2011-02-14 | 2018-11-27 | Resmed Limited | Cushion-to-frame component for an interfacing structure |
WO2012140514A1 (en) | 2011-04-15 | 2012-10-18 | Fisher & Paykel Healthcare Limited | Interface comprising a rolling nasal bridge portion |
US10603456B2 (en) | 2011-04-15 | 2020-03-31 | Fisher & Paykel Healthcare Limited | Interface comprising a nasal sealing portion |
US9498589B2 (en) | 2011-12-31 | 2016-11-22 | Covidien Lp | Methods and systems for adaptive base flow and leak compensation |
CN104066473B (en) * | 2012-01-16 | 2017-06-30 | 皇家飞利浦有限公司 | Patient interface device with the engineered surface for providing the user low friction and the comfort level for improving |
WO2013136221A1 (en) | 2012-03-13 | 2013-09-19 | Koninklijke Philips N.V. | Patient interface device having multi-chamber adjustable cushion, and apparatus and method for adjusting same |
US10028859B2 (en) * | 2012-03-27 | 2018-07-24 | Koninklijke Philips N.V. | User interface device providing for improved cooling of the skin |
JP6271524B2 (en) * | 2012-05-16 | 2018-01-31 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Patient interface device |
GB2558822B8 (en) | 2012-08-08 | 2019-04-10 | Fisher & Paykel Healthcare Ltd | Headgear for patient interface |
EP2892596B1 (en) | 2012-09-04 | 2023-07-26 | Fisher&Paykel Healthcare Limited | Valsalva mask |
US10413692B2 (en) | 2013-02-04 | 2019-09-17 | ResMed Pty Ltd | Cushion assembly |
US10004867B2 (en) | 2013-02-04 | 2018-06-26 | Resmed Limited | Respiratory apparatus |
CN107583160B (en) | 2013-02-04 | 2021-06-29 | 瑞思迈私人有限公司 | Breathing apparatus |
US10987477B2 (en) | 2013-02-04 | 2021-04-27 | ResMed Pty Ltd | Respiratory apparatus |
USD884152S1 (en) * | 2016-10-24 | 2020-05-12 | ResMed Pty Ltd | Patient interface |
EP2964301B1 (en) * | 2013-03-04 | 2019-07-17 | Fisher & Paykel Healthcare Limited | Patient interfaces with condensation reducing or compensating arrangements |
US9675771B2 (en) | 2013-10-18 | 2017-06-13 | Covidien Lp | Methods and systems for leak estimation |
WO2015065750A1 (en) | 2013-10-30 | 2015-05-07 | Balboa Manufacturing Company, Llc | Balaclava with removable face mask |
JP7117103B2 (en) | 2014-08-25 | 2022-08-12 | フィッシャー アンド ペイケル ヘルスケア リミテッド | Respirators and related parts, components or subassemblies |
TWI780489B (en) | 2014-09-16 | 2022-10-11 | 紐西蘭商費雪 & 佩凱爾關心健康有限公司 | Intramold headgear |
US10646680B2 (en) | 2014-09-19 | 2020-05-12 | Fisher & Paykel Healthcare Limited | Headgear assemblies and interface assemblies with headgear |
EP4233957A3 (en) * | 2015-07-20 | 2023-09-20 | ResMed Pty Ltd | Patient interface with volume reducing member |
EP3429668B1 (en) | 2016-03-16 | 2021-11-10 | Fisher & Paykel Healthcare Limited | Strap assembly |
SG11201807705RA (en) | 2016-03-16 | 2018-10-30 | Fisher & Paykel Healthcare Ltd | Directional lock for interface headgear arrangement |
SG10202009031VA (en) | 2016-03-16 | 2020-10-29 | Fisher & Paykel Healthcare Ltd | Intra-mould substrate |
EP3562538B1 (en) * | 2016-12-30 | 2023-05-03 | Fisher & Paykel Healthcare Limited | Thermoformed mask |
USD823454S1 (en) | 2017-02-23 | 2018-07-17 | Fisher & Paykel Healthcare Limited | Cushion assembly for breathing mask assembly |
USD823455S1 (en) | 2017-02-23 | 2018-07-17 | Fisher & Paykel Healthcare Limited | Cushion assembly for breathing mask assembly |
USD824020S1 (en) | 2017-02-23 | 2018-07-24 | Fisher & Paykel Healthcare Limited | Cushion assembly for breathing mask assembly |
CA3093955A1 (en) | 2018-03-16 | 2019-09-19 | Fisher & Paykel Healthcare Limited | Headgear with lock disengagement mechanism |
EP4249025A3 (en) | 2018-06-26 | 2023-11-29 | ResMed Pty Ltd | Headgear tubing for a patient interface |
USD941993S1 (en) * | 2019-08-23 | 2022-01-25 | ResMed Pty Ltd | Tube headgear for patient interface |
US20210330907A1 (en) * | 2020-04-27 | 2021-10-28 | Koninklijke Philips N.V. | Gas evacuating patient interface |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020108613A1 (en) * | 1999-02-09 | 2002-08-15 | Resmed Limited | Mask cushion and frame assembly |
US20030168063A1 (en) * | 2002-03-08 | 2003-09-11 | Gambone Anthony Joseph | Pressure face mask and nasal mask |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4770169A (en) * | 1987-02-13 | 1988-09-13 | Mdt Diagnostic Company | Anaesthetic mask |
US6082360A (en) * | 1995-05-04 | 2000-07-04 | Hans Rudolph, Inc. | Mask with gel seal |
US5647357A (en) * | 1995-09-08 | 1997-07-15 | Respironics, Inc. | Respiratory mask facial seal |
US5662101A (en) * | 1995-12-07 | 1997-09-02 | Respironics, Inc. | Respiratory facial mask |
US6035852A (en) * | 1996-08-30 | 2000-03-14 | Hoftman; Moshe | Inflated cuff anesthesia/respirator mask with improved nasal/maxilla bone adaptation |
US6834650B1 (en) | 1999-03-12 | 2004-12-28 | Mallinckrodt, Inc. | Face or nose mask for non-invasive ventilation of patients in general |
US6357440B1 (en) * | 1999-06-16 | 2002-03-19 | Mallinckrodt Inc. | Pliable respiratory mask |
US6418928B1 (en) * | 2000-09-25 | 2002-07-16 | Mallinckrodt Inc. | Multi-seal respirator mask |
US20030029455A1 (en) | 2001-04-03 | 2003-02-13 | Smith Christopher G. | Respiratory mask |
DE60225273T2 (en) * | 2001-05-18 | 2009-03-19 | Smaldone, Gerald C. | Face masks for pressure-applied drug delivery systems |
US6651661B2 (en) * | 2002-03-12 | 2003-11-25 | Adrian A. Matioc | Ergonomic face mask |
US7845353B2 (en) * | 2002-08-20 | 2010-12-07 | Aeiomed, Inc. | Face mask support |
US7044130B2 (en) * | 2003-02-28 | 2006-05-16 | Sunrise Medical Hhg Inc. | Adjustable nasal mask |
US7640933B1 (en) * | 2004-02-13 | 2010-01-05 | RIC Investment, Inc. | Hybrid textured/polished respiratory mask seal and respiratory mask using same |
WO2006102708A1 (en) | 2005-04-01 | 2006-10-05 | Resmed Limited | Mask pressure regulation in cpap treatment and assisted respiration by dynamic control of mask vent flow |
US7287528B2 (en) | 2005-04-13 | 2007-10-30 | Ric Investments, Llc | Cushion inside a cushion patient interface |
US7743768B2 (en) * | 2005-12-20 | 2010-06-29 | Ric Investments, Llc | Patient interface device with dampening cushion |
WO2009062265A1 (en) * | 2007-11-15 | 2009-05-22 | Resmed Ltd | A cushioning structure |
-
2008
- 2008-06-06 US US12/134,801 patent/US9782553B2/en active Active
-
2017
- 2017-08-31 US US15/692,479 patent/US20170361046A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020108613A1 (en) * | 1999-02-09 | 2002-08-15 | Resmed Limited | Mask cushion and frame assembly |
US20030168063A1 (en) * | 2002-03-08 | 2003-09-11 | Gambone Anthony Joseph | Pressure face mask and nasal mask |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021245668A1 (en) * | 2020-06-03 | 2021-12-09 | Inspir Labs Ltd. | Medical ventilation mask |
Also Published As
Publication number | Publication date |
---|---|
US20090014007A1 (en) | 2009-01-15 |
US9782553B2 (en) | 2017-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20170361046A1 (en) | Patient interface and non-invasive positive pressure ventilating method | |
US11110241B2 (en) | Fabric cushion member | |
US10737052B2 (en) | Fluid coupling member including valve member | |
JP6258924B2 (en) | Sealing cushion and patient interface device using the same | |
US20170319808A1 (en) | Patient interface device with drawstring adjustment | |
US9981103B2 (en) | Sealing cushion having angled sealing flap | |
US20150013685A1 (en) | Patient interface with expandable nasal prongs | |
US20150246199A1 (en) | Articulating full face mask | |
US20150144139A1 (en) | Patient interface device having a residual leak seal cushion | |
US11484682B2 (en) | Humidifier with ingress protection for use in CPAP therapy | |
US20140196720A1 (en) | Nasal cushion including a confortable septum/nare seal | |
US11819613B2 (en) | Nasal pillows cushion for patient interface device | |
US11623063B2 (en) | Humidifier with ingress protection for use in CPAP therapy | |
US20220288338A1 (en) | Customizable mask and method of sizing | |
EP3522967B1 (en) | Magnetic anti-crush feature for conduit | |
US20190388645A1 (en) | Patient interface valve arrangment | |
US20210128862A1 (en) | Cushion with buckling prevention structure | |
JP7471282B2 (en) | Humidifier with ingress protection for use in CPAP therapy | |
US20230398317A1 (en) | Exhaust diffuser arrangement and cpap mask including same | |
US20200197650A1 (en) | Flexible airway and seal and patient interface device including same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: RESMED LIMITED, AUSTRALIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BRAMBILLA, ENRICO;FLOWER (FORMERLY RENEE FRANCES DOHERTY), RENEE FRANCES;KWOK, PHILIP RODNEY;SIGNING DATES FROM 20080521 TO 20080606;REEL/FRAME:043464/0121 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: RESMED PTY LTD, AUSTRALIA Free format text: CHANGE OF NAME;ASSIGNOR:RESMED LIMITED;REEL/FRAME:050005/0461 Effective date: 20190301 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |